Fu‐Ming Shen

3.6k citations
113 papers · 2.7k · 1 hit paper · h-index 29

Impact in

Papers in

Fu‐Ming Shen

109 papers receiving 2.7k citations

Fu‐Ming Shen's Hit Papers

Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis 2022 · 138 citations
1380+1+2Years since publication4080120

Peers

Fu‐Ming Shen
Comparison fields: 5 of 133
  • Neurology 305
  • Cardiology and Cardiovascular Medicine 573
  • Geriatrics and Gerontology 78
  • Behavioral Neuroscience 64
  • Endocrine and Autonomic Systems 113
Replace Raffaella Mastrocola with:
Raffaella Mastrocola Italy
Yi Chu United States
Allison B. Reiss United States
Rafal R. Nazarewicz United States
Concepción Peiró Spain
Goji Hasegawa Japan
Francisco J. Rios United Kingdom
Delyth Graham United Kingdom
Shokei Kim‐Mitsuyama Japan
Wensheng Chen China
Fu‐Ming Shen relative to Raffaella Mastrocola Italy Raffaella Mastrocola's profile →
Citations per field
00.5×
Raffaella Mastrocola · 1×
Citations per year

Countries citing papers authored by Fu‐Ming Shen

Since Specialization
Citations

This map shows the geographic impact of Fu‐Ming Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu‐Ming Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu‐Ming Shen more than expected).

Fields of papers citing papers by Fu‐Ming Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu‐Ming Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu‐Ming Shen. The network helps show where Fu‐Ming Shen may publish in the future.

Co-authors

The 25 scholars most cited alongside Fu‐Ming Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fu‐Ming Shen Line = papers co-authored together Fu‐Ming Shen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011244
2
Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis
Hit paper breakdown →
2022138
3 2018125
4 2020120
5 201089
6 201667
7 202162
8 202257
9 201656
10 200953
11 201452
12 200449
13 201448
14 200747
15 202046
16 202246
17 201946
18 201744
19 202443
20 201443

About Fu‐Ming Shen

Fu‐Ming Shen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Neurology, Physiology and Pulmonary and Respiratory Medicine, having authored 113 papers that have together received 2.7k indexed citations. Recurring topics across this work include Heart Rate Variability and Autonomic Control (24 papers), Vagus Nerve Stimulation Research (17 papers), Nicotinic Acetylcholine Receptors Study (15 papers), Blood Pressure and Hypertension Studies (10 papers), Biochemical effects in animals (7 papers), Receptor Mechanisms and Signaling (6 papers), Inflammasome and immune disorders (6 papers) and Stress Responses and Cortisol (6 papers). The work is most often cited by research in Neurology (305 citations), Cardiology and Cardiovascular Medicine (573 citations), Geriatrics and Gerontology (78 citations), Behavioral Neuroscience (64 citations) and Endocrine and Autonomic Systems (113 citations). Fu‐Ming Shen has collaborated with scholars based in China, United States and France. Frequent co-authors include Dongjie Li, Ding‐Feng Su, Ding‐Feng Su, Hui Fu, Min Ni, He‐Hui Xie, Pei Wang, Jie Tong, Yiming Cao and Xianxing Jiang. Their work appears in journals such as Acta Pharmacologica Sinica, Journal of Cardiovascular Pharmacology, Clinical and Experimental Pharmacology and Physiology, Nature Communications and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact